#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=15.07.2023:
#Text=Lett symptomforverring ved 7.5mg Prednisolon.
1-1	0-10	15.07.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-16	Lett	_	_	_	_	
1-4	17-34	symptomforverring	OVERLAP	CONDITION	_	_	
1-5	35-38	ved	_	_	_	_	
1-6	39-44	7.5mg	BEFOREOVERLAP[1]	TREATMENT[1]	_	_	
1-7	45-56	Prednisolon	BEFOREOVERLAP[1]	TREATMENT[1]	_	_	
1-8	56-57	.	_	_	_	_	

#Text=Øker forbigående til 10mg.
2-1	58-62	Øker	AFTER[2]	TREATMENT[2]	OVERLAP	5-1[4_2]	
2-2	63-74	forbigående	AFTER[2]	TREATMENT[2]	_	_	
2-3	75-78	til	AFTER[2]	TREATMENT[2]	_	_	
2-4	79-83	10mg	AFTER[2]	TREATMENT[2]	_	_	
2-5	83-84	.	_	_	_	_	

#Text=Bentetthetsprofylakse fortsetter.
3-1	85-106	Bentetthetsprofylakse	AFTER	TREATMENT	OVERLAP	5-1[4_0]	
3-2	107-117	fortsetter	_	_	_	_	
3-3	117-118	.	_	_	_	_	

#Text=Planlegger videre nedtrapping over 6 måneder.
4-1	119-129	Planlegger	_	_	_	_	
4-2	130-136	videre	AFTER[3]	TREATMENT[3]	OVERLAP	5-1[4_3]	
4-3	137-148	nedtrapping	AFTER[3]	TREATMENT[3]	_	_	
4-4	149-153	over	_	_	_	_	
4-5	154-155	6	_	_	_	_	
4-6	156-163	måneder	_	_	_	_	
4-7	163-164	.	_	_	_	_	

#Text=Følges fortsatt av revmatolog.
5-1	165-171	Følges	AFTER[4]	TREATMENT[4]	_	_	
5-2	172-180	fortsatt	AFTER[4]	TREATMENT[4]	_	_	
5-3	181-183	av	AFTER[4]	TREATMENT[4]	_	_	
5-4	184-194	revmatolog	AFTER[4]	TREATMENT[4]	_	_	
5-5	194-195	.	_	_	_	_	
